SOPs for Injectables V 2.0

This SOP describes the procedure for identification and quantification of residual solvents in injectable pharmaceutical formulations using Gas Chromatography (GC). The purpose is to ensure that residual solvent levels comply with regulatory limits as per ICH Q3C guidelines, thereby ensuring product safety and patient health.
Click to read the full article.

This SOP defines the process for monitoring container closure system (CCS) integrity for sterile injectable products to ensure they maintain sterility and prevent contamination. The procedure supports compliance with regulatory expectations, such as those from the FDA, USP , and Annex 1 of EU GMP.
Click to read the full article.

This Standard Operating Procedure (SOP) describes the process for handling Out-of-Specification (OOS) results observed during analysis in the Quality Control (QC) laboratory. It ensures that all OOS incidents are investigated thoroughly and in a structured manner to determine the root cause and take appropriate corrective and preventive actions (CAPA).
Click to read the full article.

This Standard Operating Procedure (SOP) describes the method for periodic calibration of instruments and equipment used in the Quality Control (QC) laboratory to ensure they function accurately and reliably within specified parameters. The calibration ensures the validity of test results, thereby maintaining compliance with GMP and regulatory requirements.
Click to read the full article.

The purpose of this SOP is to define a systematic procedure to ensure the accuracy of in-process weight checks during the manufacturing of sterile injectable products. It helps to maintain compliance with GMP regulations and ensure consistency and quality of the final product.
Click to read the full article.

This SOP describes the process and responsibilities for real-time monitoring of vial fill levels during sterile injectable manufacturing to ensure consistent fill volumes, reduce product rejects, and comply with GMP and regulatory requirements.
Click to read the full article.

To define the procedure for inspecting filled syringes before sealing to ensure compliance with quality standards, detect defects, and maintain sterility and product integrity in aseptic manufacturing operations.
Click to read the full article.

This SOP describes the procedure for ensuring uniform and consistent mixing of raw materials and excipients during solution preparation for sterile injectable products. Proper mixing is critical for achieving homogeneity, reproducibility, and compliance with GMP and product specifications.
Click to read the full article.

This SOP defines the process for conducting microbial monitoring during the aseptic filling of sterile injectable products. The objective is to detect and control microbial contamination in critical manufacturing environments, ensuring product sterility and regulatory compliance.
Click to read the full article.

This SOP establishes a standardized procedure for preventing and controlling particle contamination in aseptic areas. The goal is to ensure product sterility and compliance with cGMP and regulatory standards, including WHO, EU GMP Annex 1, and US FDA guidance.
Click to read the full article.